Cargando…
长春瑞滨联合异环磷酰胺三线以后治疗晚期非小细胞肺癌的疗效和不良反应
BACKGROUND AND OBJECTIVE: Patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) should be treated with first-line and second-line chemotherapy or target therapy according to the lung cancer guidelines. However, no recommended treatments are available after failure to these...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999901/ https://www.ncbi.nlm.nih.gov/pubmed/26104891 http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.04 |